IL10 and inflammatory bowel disease: In an IL10−/− mouse model of IBD, another S1PR agonist, KRP-203 was shown to reduce TH1 response and colitis, which was associated with T cell trafficking [94] and linked to previously identified effects of S1P on T cells [50] (Table 2).